Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 2,725-2,736 of 10,592
Drug study icon
CompletedNCT00477672

Safety study of safety and Efficacy of Pimavanserin in Schizophrenia

This study is completed in the United States, in France, in the United Kingdom, .... It is testing safety and Efficacy of Pimavanserin for Schizophrenia.

In United States
SchizophreniaDrugA study involving a medication or substance.Over 40 Years
Countries
United States, France, United Kingdom, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT04479852

Safety and Efficacy of SP-624 for depression

This study is completed in the United States. It is testing Safety and Efficacy of SP-624 for depression.

In United States
DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Sirtsei Pharmaceuticals, Inc.
Condition
Depression
Drug study icon
CompletedNCT00650611

Safety study of ziprasidone in Schizophrenia

This study is completed in the United States. It is testing ziprasidone for Schizophrenia.

In United States
Schizophrenia, BipolarityDrugFrom 10 Years to 17 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT00550238

Safety study of pimavanserin in Schizophrenia

This study is completed in the United States, in France, in Canada, .... It is testing pimavanserin for Schizophrenia.

In United States
SchizophreniaDrugOver 40 Years
Countries
United States, France, Canada, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT04132557

A Study on Suicide prevention, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine

This study exists to learn from real-world information that can show how a therapy or guided support program fits into care. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In United States
Suicidality, SchizophreniaDrug
Countries
United States
Sponsor
Janssen Research & Development, LLC
Condition
Suicidality, Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.